Human immunodeficiency virus and the brain

Annual Review of Neuroscience

Volumn 19, Issue , 1996, Pages 1-26

  Glass, Jonathan D ^a   Johnson, Richard T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; dementia; neurology; neuropathology; neurotoxicity

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARACHIDONIC ACID METABOLISM; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE FUNCTION; MEDIATOR RELEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0029987899     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.ne.19.030196.000245     Document Type: Review

References (149)

1. Achim CL, Wang R, Miners DK, Wiley CA. 1994. Brain viral burden in HIV infection. J. Neuropathol. Exp. Neurol. 53:284-94
2. Agy MB, Frumkin LR, Corey L, Coombs RW, Wolinsky SM, et al. 1992. Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science 257:103-6
3. Anderson RM, May RM, Boily MC, Garnett GP, Rowley JT. 1991. The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS. Nature 352:581-88
4. Aylward EH, Henderer JD, McArthur JC, Brettschneider PD, Harris GJ, et al. 1993. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43:2099-104
5. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. 1993. Cytotoxicity of microglia. Glia 7:111-18
6. Barna BP, Estes ML, Jacobs BS, Hudson S, Ransohoff RM. 1990. Human astrocytes proliferate in response to tumor necrosis factor alpha. J. Neuroimmunol. 30:239-43
7. Barnett SW, Murthy KK, Herndier BG, Levy JA. 1994. An AIDS-like condition induced in baboons by HIV-2. Science 266:642-46
8. Bell JE, Busuttil A, Ironside JW, Rebus S, Donaldson YK, et al. 1993. Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J. Infect. Dis. 168:818-24
9. Belman AL, Diamond G, Dickson D, Horoupian D, Llena J, et al. 1988. Pediatric acquired immunodeficiency syndrome: neurological syndromes. Am. J. Dis. Child. 142: 29-35
10. Benos DJ, Hahn BH, Bubien JK, Ghosh SK, Mashburn NA, et al. 1994a. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc. Natl. Acad. Sci. USA 91:494-98
11. + exchange in astrocytes. J. Biol. Chem. 269:13811-16
12. Benveniste EN. 1994. Cytokine circuits in brain: implications for AIDS dementia complex. In HIV, AIDS, and the Brain, ed. RW Price, SW Perry, pp. 71-88. New York: Raven
13. Bernton EW, Bryant HU, Decoster MA, Orenstein JM, Ribas JL, et al. 1992. No direct neuronotoxicity by HIV-1 virions or culture fluids from HIV-1-infected T cells or monocytes. AIDS Res. Hum. Retroviruses 8:495-503
14. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, et al. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 353:639-42
15. Brew BJ, Bhalla RB, Fleisher M, Paul M, Khan A, et al. 1989. Cerebrospinal fluid beta2 microglobulin in patients infected with human immunodeficiency virus. Neurology 39:830-34
16. Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, et al. 1990. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann. Neurol. 28:556-60
17. Brustle O, Spiegel H, Leib SL, Finn T, Stein H, et al. 1992. Distribution of human immunodeficiency virus (HIV) in the CNS of children with severe HIV encephalomyelopathy. Acta Neuropathol. 84:24-31
18. Budka H. 1991. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1:163-75
19. Cheng-Mayer C, Weiss C, Seto D, Levy JA. 1989. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc. Natl. Acad. Sci. USA 86:8575-79
20. Chesebro B, Wehrly K, Nishio J, Perryman S. 1992. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-54
21. Chung IY, Benveniste EN. 1990. Tumor necrosis factor-alpha production by astrocytes: induction by lipopolysaccharide, IFN-gamma and IL-1beta. J. Immunol. 144:2999-3007
22. Ciardi A, Sinclair E, Scaravilli F, Harcourt-Webster NJ, Lucas S. 1990. The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study. Acta Neuropathol. 81:51-59
23. H2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-11
24. Clouse KA, Cosentino LM, Weih KA, Pyle SW, Robbins PB, et al. 1991. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J. Immunol. 147:2892-901
25. Cupp C, Taylor JP, Khalili K, Amini S. 1993. Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8: 2231-36
26. Cvetkovich TA, Lazar E, Blumberg BM, Saito Y, Estin TA, et al. 1992. Human immunodeficiency virus type 1 infection of neural xenografts. Proc. Natl. Acad. Sci. USA 89: 5162-66
27. Dal Pan GJ, Glass JD, McArthur JC. 1994. Clinicopathological correlations on HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study. Neurology 44: 2159-64
28. Dal Pan GJ, McArthur JH, Aylward E, Seines OA, Nance-Sproson TE, et al. 1992. Patterns of cerebral atrophy in HIV-1 infected individuals: results of a quantitative MRI analysis. Neurology 42:2125-30
29. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, et al. 1992. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42:1736-39
30. Dawson VL, Dawson TM, Uhl GR, Snyder SH. 1993. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA 90:3256-59
31. de la Monte SM, Gabuzda DH, Ho DD, Brown RH, Hedley-Whyte ET, et al. 1988. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann. Neurol. 23:485-92
32. Dhawan S, Toro LA, Jones E, Meltzer MS. 1992. Interactions between HIV-infected monocytes and the extracellular matrix: HIV-infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices. J. Leukoc. Biol. 52: 244-48
33. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA. 1990. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:364-67
34. 2alpha levels in human cerebrospinal fluid in normal and pathological conditions. J. Neurol. 222:239-48
35. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, et al. 1991. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 180:583-90
36. Everall I, Luthert P, Lantos P. 1993. A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J. Neuropathol. Exp. Neurol. 52:561-66
37. Everall IP, Glass JD, McArthur JC, Spargo E, Lantos P. 1994. Neuronal loss in the superior frontal and temporal gyri does not correlate with the degree of HIV-associated dementia. Acta Neuropathol. 88:538-44
38. Everall IP, Luthbert PJ, Lantos PL. 1991. Neuronal loss in the frontal cortex in HIV infection. Lancet 337:1119-21
39. Gallo P, de Rossi A, Sivieri S, Chieco-Bianchi L, Tavolato B. 1994. M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis: implications for neurological HIV-1-related disease. J. Neuroimmunol. 51:193-98
40. Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, et al. 1989. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23: 109-16
41. Gelbard HA, Nottet HSLM, Swindells S, Jett M, Dzenko KA, et al. 1994. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:4628-35
42. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, et al. 1992. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1703-18
43. Georgsson G, Houwers DJ, Palsson PA, Petursson G. 1989. Expression of viral antigens in the central nervous system of visna-infected sheep: an immunohistochemical study on experimental visna induced by virus strains of increased neurovirulence. Acta Neuropathol. 77:299-306
44. Giulian D, Vaca K, Noonan CA. 1990. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250: 1593-96
45. Glass JD, Wesselingh SL, Selnes OA, McArthur JC. 1993. Clinical-neuropathological correlation in HIV-associated dementia. Neurology 43:2230-37
46. Goudsmit J, Paul DA, Lange JMA, Speelman H, Van der Noordaa J, et al. 1986. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 1:177-80
47. Gray F, Gherardi R, Scaravilli F. 1988. The neuropathology of the acquired immune deficiency syndrome (AIDS): a review. Brain 111:245-66
48. Griffin DE, Wesselingh SL, McArthur JC. 1994. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35: 592-97
49. Griffin GE, Leung K, Folks TM, Kunkel S, Nabel GJ. 1991. Induction of NF-xB during monocyte differentiation is associated with activation of HIV-gene expression. Res. Virol. 142:233-38
50. Griffin JW, Crawford TO, Tyor WR, Glass JD, Price DL, et al. 1995a. Sensory neuropathy in AIDS. I. Neuropathology. Brain. In press
51. Griffin JW, Tyor WR, Glass JD, Crawford TO, Griffin DE, et al. 1995b. Sensory neuropathy in AIDS. II. Immunopathology. Brain. In press
52. Grimaldi LME, Martino GV, Franciotta DM, Brustia R, Castagna A, et al. 1991. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann. Neurol. 29:21-25
53. Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, et al. 1991. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253: 320-22
54. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, et al. 1991. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:202-9
55. Heyes MP, Gravell M, London WT, Eckhaus M, Vickers JH, et al. 1990. Sustained increases in cerebrospinal fluid quinolinic acid concentrations of rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type D. Brain Res. 531:148-58
56. Heyes MP, Nowak TSJ, 1990. Delayed increases in regional brain quinolinic acid follow transient ischemia in the gerbil. J. Cereb. Blood Flow Metab. 10:660-67
57. Heyes MP, Rubinow D, Lane C, Markey SP. 1989. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann. Neurol. 26: 275-77
58. Heyes MP, Saito K, Major EO, Milstien S, Markey SP, et al. 1993. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease: attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116:1425-50
59. Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE. 1993. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res. 603:222-33
60. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, et al. 1985. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Med. 313:1493-97
61. Johnson RT, McArthur JC, Narayan O. 1988. The neurobiology of human immunodeficiency virus infection. FASEB J. 2:2970-81
62. Ketzler S, Weis S, Haug H, Budka H. 1990. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. 80:92-94
63. Keys B, Karis J, Fadeel B, Valentin A, Norkrans G, et al. 1993. V3 sequence of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 196:475-83
64. Kimura-Kuroda J, Nagashima K, Yasui K. 1994. Inhibition of myelin formation by HIV-1 gp120 in rat cerebral cortex culture. Arch. Virol. 137:81-99
65. Kleihues P, Lang W, Burger FC, Budka H, Vogt M, et al. 1985. Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS). Acta Neuropathol. 68:333-39
66. Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, et al. 1991. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum. Pathol. 22:700-10
67. Levy JA. 1994. HIV and the Pathogenesis of AIDS. Washington, DC: ASM
68. Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L. 1985. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 2:586-88
69. Li Y, Hui H, Burgess CJ, Price RW, Sharp PM, et al. 1992. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J. Virol. 66:6587-600
70. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, et al. 1991. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 65:3973-85
71. Lieberman AP, Pitha PM, Shin ML. 1990. Protein kinase regulates tumor necrosis factor mRNA stability in virus-stimulated astrocytes. J. Exp. Med. 172:989-92
72. Lipton SA. 1994a. HIV displays its coat of arms. Nature 367:113-14
73. Lipton SA. 1994b. HIV coat protein gp120 induces soluble neurotoxins in culture medium. Neurosci. Res. Commun. 15:31-37
74. Lipton SA, Rosenberg PA. 1994. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330: 613-21
75. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. 1991. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111-18
76. Mann JM. 1993. AIDS in the 1990s: a global analysis. The Pharos 56:2-5
77. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, et al. 1992. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest. 66:285-91
78. Masuda M, Remington MP, Hoffman PN, Ruscetti SK. 1992. Molecular characterization of a neuropathologic and non-erythroleukemogenic variant of Friend murine leukemia virus PVC-211. J. Virol. 66:2798-806
79. Mayhew TM. 1992. A review of recent advances in stereology for quantifying neural structure. J. Neurocytol. 21:313-28
80. McArthur JC. 1987. Neurologic manifestations of AIDS. Medicine 66:407-37
81. McArthur JC, Becker PS, Parisi J, Trapp BD, Selnes OA, et al. 1989. Neuropathological changes in early HIV dementia. Ann. Neurol. 26:681-84
82. McArthur JC, Cohen BA, Farzedegan H, Cornblath DR, Selnes OA, et al. 1988. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann. Neurol. 23:S34-S37 (Suppl.)
83. McArthur JC, Harrison MJG. 1994. HIV-associated dementia. In Current Neurology, 14: 275-320. St. Louis: Mosby-Year Book
84. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, et al. 1993. Dementia in AIDS patients: incidence and risk factors. Neurology 43:2245-52
85. 2-microglobulin in HIV-1 dementia. Neurology 42:1707-12
86. Mellors JW, Griffith BP, Ortiz MA, Landry ML, Ryan JL. 1991. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J. Infect. Dis. 163:78-82
87. Merrill JE, Chen ISY. 1991. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5:2391-97
88. Merrill JE, Gerner RH, Myers LW, Ellison GW. 1983. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J. Neuroimmunol. 4:223-37
89. Mintz M, Rapaport R, Oleske JM, Connor EM, Koenigsberger MR, et al. 1989. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am. J. Dis. Child. 143:771-74
90. Morganti-Kossmann MC, Kossmann T, Wahl SM. 1992. Cytokines and neuropathology. Trends Physiol. Sci. 13:286-91
91. Moses AV, Bloom FE, Pauza CD, Nelson JA. 1993. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. Natl. Acad. Sci. USA 190:10474-78
92. Mosmann TR. 1994. Cytokine patterns during the progression to AIDS. Science 265:193-94
93. Murray EA, Rausch DM, Lendvay J, Sharer LR, Eiden LE. 1992. Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 255:1246-49
94. Narayan O, Clements JE. 1989. Biology and pathogenesis of lentiviruses [Review]. J. Gen. Virol. 70:1617-39
95. Navia BA, Cho E-S, Petito CK, Price RW. 1986a. The AIDS dementia complex. II. Neuropathology. Ann. Neurol. 19:525-35
96. Navia BA, Jordan BD, Price RW. 1986b. The AIDS dementia complex. I. Clinical features. Ann. Neurol. 19:517-24
97. Nuovo GJ, Gallery F, MacConnell P, Braun A. 1994. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am. J. Pathol. 144:659-66
98. Oster S, Christoffersen P, Gundersen HJG, Nielsen JO, Pakkenberg B, et al. 1993. Cerebral atrophy in AIDS: a stereological study. Acta Neuropathol. 85:617-22
99. Pang S, Vinters HV, Akashi T, O'Brien WA, Chen ISY. 1991. HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J. AIDS 4: 1082-92
100. Petito CK, Cash KS. 1992. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann. Neurol. 32:658-66
101. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, et al. 1985. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 312:874-79
102. Petito CK, Vecchio D, Chen Y-T. 1994. HIV antigen and DNA in AIDS spinal cords correlate with macrophage infiltration but not with vacuolar myelopathy. J. Neuropathol. Exp. Neurol. 53:86-94
103. Phillips TR, Prospero-Garcia O, Puaoi DL, Lerner DL, Fox HS, et al. 1994. Neurological abnormalities associated with feline immunodeficiency virus infection. J. Gen. Virol. 75:979-87
104. Portegies P, Epstein LG, Hung STA, de Gans J, Goudsmit J. 1989. Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Arch. Neurol. 46:261-64
105. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, et al. 1994. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J. Virol. 68: 4643-49
106. Power CP, Kong PA, Crawford TO, Wesselingh S, Glass JD, et al. 1993. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations in the blood-brain barrier. Ann. Neurol. 34:339-50
107. Preston BD, Poiesz BJ, Loeb LA. 1988. Fidelity of HIV-1 reverse transcriptase. Science 242:1168-71
108. Pulliam L, Herndier BG, Tang NM, McGrath MS. 1991. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87:503-12
109. Rausch DM, Heyes MP, Murray EA, Lendvay J, Sharer LR, et al. 1994. Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkeys. J. Neuropathol. Exp. Neurol. 53:165-75
110. Resnick L, DiMarzo-Veronese F, Schupback J, Tourtellotte WW, Ho DD, et al. 1985. Intrablood-brain-barrier synthesis of HTLV-III specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N. Engl. J. Med. 313:1498-504
111. Rhodes R. 1987. Histopathology of the central nervous system in the acquired immunodeficiency syndrome. Hum. Pathol. 18:636-43
112. Robbins DS, Shirazi Y, Drysdale BE, Lieberman A, Shin HS, et al. 1987. Production of cytotoxic factor for oligodendrocytes by stimlulated astrocytes. J. Immunol. 139: 2593-97
113. Rosenblum MK. 1990. Infection of the central nervous system by the human immunodeficiency virus type 1: morphology and relation to syndromes of progressive encephalopathy and myelopathy in patients with AIDS. Pathol. Annu. 25:117-69
114. Royal W III, Selnes OA, Concha M, Nance-Sproson TE, McArthur JC. 1994. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia. Ann. Neurol. 36:32-39
115. Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, et al. 1994. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44:474-81
116. Sasseville VG, Newman WA, Lackner AA, Smith MO, Lausen NC, et al. 1992. Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am. J. Pathol. 141:1021-30
117. Sei Y, Arora PK, Skolnick P, Paul IA. 1992. Spatial learning impairment in a murine model of AIDS. FASEB J. 6:3008-13
118. Seilhean D, Duyckaerts C, Vazeux R, Bolgert F, Brunet P, et al. 1993. HIV-1-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex. Neurology 43:1492-99
119. Selmaj KW, Raine CS. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339-46
120. Sharer LR. 1992. Pathology of HIV-1 infection of the central nervous system. A review. J. Neuropathol. Exp. Neurol. 51:3-11
121. Sharer LR, Michaels J, Murphey-Corb M, Hu F-S, Kuebler DJ, et al. 1991. Serial pathogenesis of SIV brain infection. J. Med. Primatol. 20:211-17
122. Sharma DP, Zink MC, Anderson M, Adams R, Clements JE, et al. 1992. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J. Virol. 66:3550-56
123. Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, et al. 1985. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 227:177-82
124. Shibata M, Blatteis CM. 1991. Differential effects of cytokines on thermosensitive neurons in guinea pig preoptic area slices. Am. J. Physiol. 261:R1096-103
125. Sinclair E, Scaravilli F. 1992. Detection of HIV proviral DNA in cortex and white matter of AIDS brains by non-isotopic polymerase chain reaction: correlation with diffuse poliodystrophy. AIDS 6:925-32
126. Singer EJ, Syndulko K, Fahy-Chandon BN, Shapshak P, Resnick L, et al. 1994. Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1. AIDS 8:197-204
127. Smith TW, DeGirolami U, Henin D, Bolgert F, Hauw J-J. 1990. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J. Neuropathol. Exp. Neurol. 49:357-70
128. 2+ currents in cultured sympathetic neurons. J. Neurosci. 12:2665-71
129. Tadmori W, Mondal D, Tadmori I, Prakash O. 1991. Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor-α. J. Virol. 65:6425-29
130. Tardieu M, Hery C, Peudenier S, Boespflug O, Montagnier L. 1992. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann. Neurol. 32:11-17
131. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, et al. 1994. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-93
132. Tornatore C, Chandra R, Berger JR, Major EO. 1994. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44:481-87
133. Tourtellotte WW, Schmid P, Conrad A, Syndulko K, Singer EJ, et al. 1993. Quantifying HIV-1 proviral DNA via the polymerase chain reaction (PCR) in cerebrospinal fluid (CSF) and blood of seropositive individuals with and without neurologic abnormalities. Neurology 43:A265 (Abstr.)
134. Tyor WR, Glass JD, Becker PS, Griffin JW, Bezman J, et al. 1992. Cytokine expression in the brain during AIDS. Ann. Neurol. 31: 349-60
135. Tyor WR, Power C, Gendelman HE, Markham RB. 1993. A model of human immunodeficiency virus encephalitis in scid mice. Proc. Natl. Acad. Sci. USA 90:8658-62
136. Vazeux R, Lacroix-Ciaudo C, Blanche S, Cumont M-C, Henin D, et al. 1992. Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am. J. Pathol. 140:137-44
137. Vitkovic L, Wood GP, Major EO, Fauci AS. 1991. Human astrocytes stimulate HIV-1 expression in a chronically infected promonocyte clone via interleukin-6. AIDS Res. Hum. Retroviruses 7:723-27
138. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, et al. 1989. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Immunology 86:621-25
139. Wahl SM, Allen JB, McCartney-Francis N, Morganti-Kossmann MC, Kossmann T, et al. 1991. Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. Exp. Med. 173:981-91
140. Watanabe M, Ringler DJ, Fultz PN, MacKey JJ, Boyson JE, et al. 1991. A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease. J. Virol. 65:3344-48
141. Wesselingh S, Gough NM, Finlay-Jones JJ, McDonald PJ. 1990. Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. Lymphokine Res. 9:2
142. Wesselingh SL, Glass J, McArthur JC, Griffin JW, Griffin DE. 1994. Cytokine dysregulation in HIV-associated neurological disease. Adv. Neuroimmunol. 4:199-206
143. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, et al. 1993. Intracerebral cytokine mRNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33:576-82
144. Wiley CA, Achim C. 1994. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol. 36:673-76
145. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, et al. 1991. Neocortical damage during HIV infection. Ann. Neurol. 29:651-57
146. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA. 1986. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83:7089-93
147. Williams AE, Blakemore WF. 1990. Monocyte-mediated entry of pathogens into the central nervous system. Neuropathol. Appl. Neurobiol. 16:377-92
148. Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, et al. 1995. In vitro evidence for a dual role of TNF-α in HIV-1 encephalopathy. Ann. Neurol. 37:381-94
149. Yoshioka M, Shapshak P, Srivastava AK, Stewart RV, Nelson SJ, et al. 1994. Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 44:1120-30